Methods of reducing the risk of a cardiovascular event in a subject on statin therapy
P Soni - US Patent 9,693,984, 2017 - Google Patents
In various embodiments, the present invention provides methods of reducing the risk of a
cardiovascular event in a subject on statin therapy and, in particular, a method of reducing …
cardiovascular event in a subject on statin therapy and, in particular, a method of reducing …
Methods of reducing the risk of a cardiovascular event in a subject on statin therapy
P Soni - US Patent 9,603,826, 2017 - Google Patents
In various embodiments, the present invention provides methods of reducing the risk of a
cardiovascular event in a subject on statin therapy and, in particular, a method of reducing …
cardiovascular event in a subject on statin therapy and, in particular, a method of reducing …
Compositions comprising eicosapentaenoic acid and mipomersen and methods of use thereof
JS Zakrzewski - US Patent 9,624,492, 2017 - Google Patents
US9624492B2 - Compositions comprising eicosapentaenoic acid and mipomersen and
methods of use thereof - Google Patents US9624492B2 - Compositions comprising …
methods of use thereof - Google Patents US9624492B2 - Compositions comprising …
Nebivolol: A Highly Selective β1‐Adrenergic Receptor Blocker That Causes Vasodilation by Increasing Nitric Oxide
S Gupta, HM Wright - Cardiovascular therapeutics, 2008 - Wiley Online Library
Nebivolol (Bystolic®) is a cardioselective beta 1 (β1)‐adrenergic receptor blocker with
endothelium‐dependent vasodilating properties. The endothelium‐dependent relaxation …
endothelium‐dependent vasodilating properties. The endothelium‐dependent relaxation …
Co-administration of rosiglitazone and eicosapentaenoic acid or a derivative thereof
R Braeckman, W Stirtan, P Soni - US Patent 10,966,968, 2021 - Google Patents
In various embodiments, the present invention provides methods of treating and/or
preventing cardiovascular-related disease and, in particular, a method of reducing …
preventing cardiovascular-related disease and, in particular, a method of reducing …
Compositions and methods for lowering triglycerides without raising LDL-C levels in a subject on concomitant statin therapy
I Osterloh, P Wicker, R Braeckman, P Soni… - US Patent …, 2019 - Google Patents
US10292959B2 - Compositions and methods for lowering triglycerides without raising LDL-C
levels in a subject on concomitant statin therapy - Google Patents US10292959B2 …
levels in a subject on concomitant statin therapy - Google Patents US10292959B2 …
Compositions comprising eicosapentaenoic acid and a hydroxyl compound and methods of use thereof
JS Zakrzewski - US Patent 9,855,240, 2018 - Google Patents
US9855240B2 - Compositions comprising eicosapentaenoic acid and a hydroxyl compound
and methods of use thereof - Google Patents US9855240B2 - Compositions comprising …
and methods of use thereof - Google Patents US9855240B2 - Compositions comprising …
Compositions and methods for treating or preventing obesity in a subject in need thereof
JS Zakrzewski - US Patent 9,283,201, 2016 - Google Patents
US9283201B2 - Compositions and methods for treating or preventing obesity in a subject in
need thereof - Google Patents US9283201B2 - Compositions and methods for treating or …
need thereof - Google Patents US9283201B2 - Compositions and methods for treating or …
Sex differences in the mechanisms mediating blunted cutaneous microvascular function in young black men and women
JC Patik, BM Curtis, A Nasirian… - American Journal …, 2018 - journals.physiology.org
The black population exhibits attenuated vasodilatory function across their lifespan, yet little
is known regarding the mechanisms of this impairment. Recent evidence suggests a …
is known regarding the mechanisms of this impairment. Recent evidence suggests a …
Methods of reducing triglycerides and LDL-C
I Osterloh, P Wicker, R Braeckman, P Soni… - US Patent …, 2019 - Google Patents
The present disclosure relates to, inter alia, methods of treating mixed dyslipidemia with
ethyl eicosapentaenoate.
ethyl eicosapentaenoate.